Clinical Trials Browser

Phase 3 × Vortioxetine × Head & Neck × Clear all

NCT04818099 2021-03-26

Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy

Phase 3 Unknown

Depression, Head and Neck Neoplasms, Radiation Injuries